News

These 2 Stocks Could More Than Double Your Money, According to Wall Street. Is It Time to Buy?
Key Points Analyst expectations are far above the prices you'd need to pay now to own a couple of biotechnology stocks.Compass Pathways is developing psilocybin as a treatment for depression.Viking ...
Many US employers plan to pare health benefits as weight-loss spending soars
More than half of large U.S. employers plan to scale back healthcare benefits next year as rising costs from weight-loss and ...
Zacks Investment Research on MSN3d
Eli Lilly vs. Merck: Which Drug Giant Appears Better Poised Today?
Both Eli Lilly LLY and Merck MRK are major players in the U.S. pharmaceutical industry, developing and commercializing ...
New Scientist3d
You don't need to take drugs like Ozempic consistently to lose weight
People who take GLP-1 drugs like Ozempic can lose weight even if they face disruptions in accessing the medications, which ...
Healthy Returns: Chinese obesity drug emerges as a potential rival to Eli Lilly's Zepbound
An obesity drug from Hengrui Pharma and Kailera Therapeutics succeeded in a late-stage trial in China, while Anne Wojcicki’s ...
Johnson & Johnson Q2 Earnings Review: This Is As Safe As Pharma Investing Gets
Johnson & Johnson shows steady growth in Q2, driven by medtech and oncology, yet talc litigation overshadows. Click for my ...
Here's How to Play AbbVie Stock as it Reaches Golden Cross
Detailed price information for Eli Lilly and Company (LLY-N) from The Globe and Mail including charting and trades.